CN115595250A - 一种自动化完成类器官处理及分析的系统及方法 - Google Patents
一种自动化完成类器官处理及分析的系统及方法 Download PDFInfo
- Publication number
- CN115595250A CN115595250A CN202210838292.0A CN202210838292A CN115595250A CN 115595250 A CN115595250 A CN 115595250A CN 202210838292 A CN202210838292 A CN 202210838292A CN 115595250 A CN115595250 A CN 115595250A
- Authority
- CN
- China
- Prior art keywords
- unit
- liquid
- receiving
- culture
- organoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002220 organoid Anatomy 0.000 title claims abstract description 209
- 238000012545 processing Methods 0.000 title claims abstract description 79
- 238000004458 analytical method Methods 0.000 title claims abstract description 75
- 238000000034 method Methods 0.000 title claims abstract description 25
- 239000007788 liquid Substances 0.000 claims abstract description 283
- 239000003814 drug Substances 0.000 claims abstract description 84
- 238000011282 treatment Methods 0.000 claims abstract description 44
- 229940079593 drug Drugs 0.000 claims abstract description 42
- 238000005119 centrifugation Methods 0.000 claims abstract description 25
- 238000011156 evaluation Methods 0.000 claims abstract description 24
- 238000012258 culturing Methods 0.000 claims abstract description 17
- 238000001959 radiotherapy Methods 0.000 claims abstract description 9
- 238000007877 drug screening Methods 0.000 claims abstract description 8
- 238000007711 solidification Methods 0.000 claims abstract description 5
- 230000008023 solidification Effects 0.000 claims abstract description 5
- 238000009169 immunotherapy Methods 0.000 claims abstract description 4
- 108010082117 matrigel Proteins 0.000 claims description 66
- 238000005507 spraying Methods 0.000 claims description 51
- 239000000126 substance Substances 0.000 claims description 44
- 238000004806 packaging method and process Methods 0.000 claims description 43
- 239000003153 chemical reaction reagent Substances 0.000 claims description 39
- 238000004140 cleaning Methods 0.000 claims description 29
- 210000004027 cell Anatomy 0.000 claims description 27
- 238000000926 separation method Methods 0.000 claims description 21
- 239000000463 material Substances 0.000 claims description 15
- 230000033001 locomotion Effects 0.000 claims description 14
- 206010028980 Neoplasm Diseases 0.000 claims description 12
- 210000002865 immune cell Anatomy 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 12
- 230000005855 radiation Effects 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 238000001647 drug administration Methods 0.000 claims description 10
- 230000007704 transition Effects 0.000 claims description 10
- 239000003292 glue Substances 0.000 claims description 9
- 239000011159 matrix material Substances 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- 239000002699 waste material Substances 0.000 claims description 7
- 239000012531 culture fluid Substances 0.000 claims description 6
- 230000006870 function Effects 0.000 claims description 6
- 238000011534 incubation Methods 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 210000000056 organ Anatomy 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- WSNMPAVSZJSIMT-UHFFFAOYSA-N COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 Chemical compound COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 WSNMPAVSZJSIMT-UHFFFAOYSA-N 0.000 claims description 4
- 238000002372 labelling Methods 0.000 claims description 4
- 238000005086 pumping Methods 0.000 claims description 4
- 238000003860 storage Methods 0.000 claims description 4
- 238000003501 co-culture Methods 0.000 claims description 3
- 238000010494 dissociation reaction Methods 0.000 claims description 3
- 230000005593 dissociations Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000002285 radioactive effect Effects 0.000 claims description 3
- 230000008054 signal transmission Effects 0.000 claims description 3
- 206010005949 Bone cancer Diseases 0.000 claims description 2
- 208000018084 Bone neoplasm Diseases 0.000 claims description 2
- 206010009944 Colon cancer Diseases 0.000 claims description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 2
- 230000009471 action Effects 0.000 claims description 2
- 210000004556 brain Anatomy 0.000 claims description 2
- 238000002512 chemotherapy Methods 0.000 claims description 2
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 2
- 206010017758 gastric cancer Diseases 0.000 claims description 2
- 210000003734 kidney Anatomy 0.000 claims description 2
- 210000004185 liver Anatomy 0.000 claims description 2
- 201000007270 liver cancer Diseases 0.000 claims description 2
- 208000014018 liver neoplasm Diseases 0.000 claims description 2
- 210000004072 lung Anatomy 0.000 claims description 2
- 201000005202 lung cancer Diseases 0.000 claims description 2
- 208000020816 lung neoplasm Diseases 0.000 claims description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 2
- 230000035764 nutrition Effects 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 claims description 2
- 201000002528 pancreatic cancer Diseases 0.000 claims description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 2
- 210000001778 pluripotent stem cell Anatomy 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 201000011549 stomach cancer Diseases 0.000 claims description 2
- 238000002626 targeted therapy Methods 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 231100000041 toxicology testing Toxicity 0.000 claims description 2
- 230000009466 transformation Effects 0.000 claims description 2
- 238000004148 unit process Methods 0.000 claims description 2
- 230000035899 viability Effects 0.000 claims description 2
- 239000012530 fluid Substances 0.000 abstract description 4
- 230000036961 partial effect Effects 0.000 description 9
- 238000011160 research Methods 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 206010064571 Gene mutation Diseases 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005192 partition Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
- 102400000921 Gastrin Human genes 0.000 description 2
- 108010052343 Gastrins Proteins 0.000 description 2
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940126864 fibroblast growth factor Drugs 0.000 description 2
- 238000005429 filling process Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000003578 releasing effect Effects 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010052399 Neuroendocrine tumour Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 108050003627 Wnt Proteins 0.000 description 1
- 102000013814 Wnt Human genes 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000012054 celltiter-glo Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 108010038082 heparin proteoglycan Proteins 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 201000010982 kidney cancer Diseases 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000016065 neuroendocrine neoplasm Diseases 0.000 description 1
- 201000011519 neuroendocrine tumor Diseases 0.000 description 1
- 108010008217 nidogen Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012858 packaging process Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/48—Automatic or computerized control
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/52—Mobile; Means for transporting the apparatus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/14—Scaffolds; Matrices
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/46—Means for regulation, monitoring, measurement or control, e.g. flow regulation of cellular or enzymatic activity or functionality, e.g. cell viability
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Computer Hardware Design (AREA)
- Clinical Laboratory Science (AREA)
- Immunology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2022104791177 | 2022-04-29 | ||
CN202210479117 | 2022-04-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115595250A true CN115595250A (zh) | 2023-01-13 |
Family
ID=84843627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210838292.0A Pending CN115595250A (zh) | 2022-04-29 | 2022-07-14 | 一种自动化完成类器官处理及分析的系统及方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115595250A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117227168A (zh) * | 2023-11-16 | 2023-12-15 | 山东伯桢生物科技有限公司 | 类器官打印系统及用于类器官打印系统的控制方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008220298A (ja) * | 2007-03-14 | 2008-09-25 | Mitsubishi Gas Chem Co Inc | 細胞内への物質導入方法および装置、並びにそれらによって得られた細胞 |
CN102492603A (zh) * | 2011-11-22 | 2012-06-13 | 马庆伟 | 一种用于提取核酸和质谱点样的自动化仪器 |
US20200025782A1 (en) * | 2016-06-20 | 2020-01-23 | Genesis Technologies Limited | Automated cell processing systems and methods |
WO2020215488A1 (zh) * | 2019-04-22 | 2020-10-29 | 清华-伯克利深圳学院筹备办公室 | 一种类器官球体的高通量培养方法 |
CN111876386A (zh) * | 2020-08-10 | 2020-11-03 | 上海市第一人民医院 | 一种乳腺癌类器官的培养方法以及和肿瘤相关成纤维细胞的共培养方法 |
CN113046240A (zh) * | 2021-03-12 | 2021-06-29 | 宁波大学 | 具有评价功能的细胞培养装置及方法 |
KR20210108865A (ko) * | 2020-02-25 | 2021-09-03 | 고려대학교 산학협력단 | 환자 맞춤형 약물 선택을 위한 정보 제공 방법 |
-
2022
- 2022-07-14 CN CN202210838292.0A patent/CN115595250A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008220298A (ja) * | 2007-03-14 | 2008-09-25 | Mitsubishi Gas Chem Co Inc | 細胞内への物質導入方法および装置、並びにそれらによって得られた細胞 |
CN102492603A (zh) * | 2011-11-22 | 2012-06-13 | 马庆伟 | 一种用于提取核酸和质谱点样的自动化仪器 |
US20200025782A1 (en) * | 2016-06-20 | 2020-01-23 | Genesis Technologies Limited | Automated cell processing systems and methods |
WO2020215488A1 (zh) * | 2019-04-22 | 2020-10-29 | 清华-伯克利深圳学院筹备办公室 | 一种类器官球体的高通量培养方法 |
KR20210108865A (ko) * | 2020-02-25 | 2021-09-03 | 고려대학교 산학협력단 | 환자 맞춤형 약물 선택을 위한 정보 제공 방법 |
CN111876386A (zh) * | 2020-08-10 | 2020-11-03 | 上海市第一人民医院 | 一种乳腺癌类器官的培养方法以及和肿瘤相关成纤维细胞的共培养方法 |
CN113046240A (zh) * | 2021-03-12 | 2021-06-29 | 宁波大学 | 具有评价功能的细胞培养装置及方法 |
Non-Patent Citations (1)
Title |
---|
余素芹 贵阳:贵州科技出版社: "生物技术概要", pages: 146 - 148 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117227168A (zh) * | 2023-11-16 | 2023-12-15 | 山东伯桢生物科技有限公司 | 类器官打印系统及用于类器官打印系统的控制方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6849719B2 (ja) | オートメーション化された細胞培養システム及び方法 | |
Doulgkeroglou et al. | Automation, monitoring, and standardization of cell product manufacturing | |
EP3307864B1 (en) | Cell culture incubator and cell culture method | |
EP1944359B1 (en) | Shaker for cell culture and shaken culture system in cell culture method | |
Meseguer et al. | Full in vitro fertilization laboratory mechanization: toward robotic assisted reproduction? | |
AU2009224507B2 (en) | Method and device for cell culture in the open continuous mode | |
CN108611271A (zh) | 全封闭式智能化生物生产系统及生产方法 | |
JPS6112279A (ja) | 細胞培養装置 | |
CN115595250A (zh) | 一种自动化完成类器官处理及分析的系统及方法 | |
JP2022060542A (ja) | 細胞を培養するための容器 | |
US11958050B2 (en) | Fluidic devices for closed cell culture applications under current good manufacturing practice | |
CN110913990A (zh) | 液体转移系统 | |
Ochs et al. | Needle to needle robot‐assisted manufacture of cell therapy products | |
CN219603578U (zh) | 一种有效进行类器官处理及分析的自动化系统 | |
CN108641953A (zh) | 全封闭式智能化生物生产系统及生产方法 | |
CN116875461A (zh) | 细胞培养检测设备、方法以及其应用 | |
CN219603592U (zh) | 一种自动化的类器官液体分装系统 | |
CN115612614A (zh) | 一种类器官处理前的液体分装系统 | |
CN110437976A (zh) | 一种全自动样品处理工作站及处理方法 | |
TW202235842A (zh) | 用於個人化醫療及藥物開發之微器官球體(micro-organospheres) | |
CN115184115B (zh) | 一种用微孔板混制药物微平板的制备方法 | |
CN109916817A (zh) | 一种移液及分析装置 | |
KR102577031B1 (ko) | 고속분주스폿터용 드롭 카운터모듈 및 고속분주스폿터의 제어방법 | |
CN219694996U (zh) | 蛋白质提取多肽水解自动化处理设备 | |
US20230011168A1 (en) | Bio-Chips and Production Method Thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230404 Address after: 100005 No. three, 5 Dongdan, Beijing, Dongcheng District Applicant after: INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES Address before: 100070 022, Floor 4, 1501, Building 15, Yard 26, Waihuan West Road, Fengtai District, Beijing Applicant before: Beijing Xiansheng Medical Technology Co.,Ltd. |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Song Wei Inventor after: Liu Changzheng Inventor after: Zou Dongling Inventor after: Liang Junbo Inventor before: Yu Jia Inventor before: Song Wei Inventor before: Liu Changzheng Inventor before: Liang Junbo Inventor before: Zou Dongling |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |